APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fungal Drugs for Treatment of Tinea

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fungal Drugs for Treatment of Tinea Market Outlook and Growth Opportunities 2026

21 December 2025212 pages

Choose your research edition.

Industry ResearchFungal Drugs for Treatment of Tinea Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Fungal Drugs for Treatment of Tinea Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Fungal Drugs for Treatment of Tinea Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fungal Drugs for Treatment of Tinea Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Fungal Drugs for Treatment of Tinea Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Fungal Drugs for Treatment of Tinea market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fungal Drugs for Treatment of Tinea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fungal Drugs for Treatment of Tinea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fungal Drugs for Treatment of Tinea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fungal Drugs for Treatment of Tinea market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fungal Drugs for Treatment of Tinea market include Tianjin Lisheng Pharmaceuticals, Teva Pharmaceuticals, Shanghai Modern Hasen (Shangqiu) Pharmaceuticals, Shandong Qilu Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Shandong Jingwei Pharmaceutical, Sandoz, Johnson & Johnson and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Fungal Drugs for Treatment of Tinea market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fungal Drugs for Treatment of Tinea and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fungal Drugs for Treatment of Tinea revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fungal Drugs for Treatment of Tinea market.

Fungal Drugs for Treatment of Tinea Segment by Company

Tianjin Lisheng Pharmaceuticals

Teva Pharmaceuticals

Shanghai Modern Hasen (Shangqiu) Pharmaceuticals

Shandong Qilu Pharmaceuticals

Shandong Luoxin Pharmaceuticals

Shandong Jingwei Pharmaceutical

Sandoz

Johnson & Johnson

Novartis

Jiangsu Zhiyuan Pharmaceutical

Jiangsu Yunyang Group Pharmaceuticals

Hubei Hengan Fulin

Hainan Kangzhi Pharmaceuticals

Harbin Sanlian Pharmaceuticals

Guilin Huaxin Pharmaceuticals

GSK

Chengdu Beite Pharmaceuticals

Bayer

Ultratech India

Perrigo

Padagis

Kaken Pharmaceutical

Gufic Biosciences

Galderma

Bausch Health

Fungal Drugs for Treatment of Tinea Segment by Type

Topical Drugs

Oral Drugs

Fungal Drugs for Treatment of Tinea Segment by Application

Hospital Pharmacy

Online

Retail Pharmacy

Fungal Drugs for Treatment of Tinea Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fungal Drugs for Treatment of Tinea status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Fungal Drugs for Treatment of Tinea key companies, revenue, market share, and recent developments.

3. To split the Fungal Drugs for Treatment of Tinea breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Fungal Drugs for Treatment of Tinea market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fungal Drugs for Treatment of Tinea significant trends, drivers, influence factors in global and regions.

6. To analyze Fungal Drugs for Treatment of Tinea competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Drugs for Treatment of Tinea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fungal Drugs for Treatment of Tinea and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Drugs for Treatment of Tinea.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fungal Drugs for Treatment of Tinea industry.

Chapter 3: Detailed analysis of Fungal Drugs for Treatment of Tinea company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Fungal Drugs for Treatment of Tinea in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Fungal Drugs for Treatment of Tinea in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fungal Drugs for Treatment of Tinea Industry Trends Table 2. Fungal Drugs for Treatment of Tinea Industry Drivers Table 3. Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges Table 4. Fungal Drugs for Treatment of Tinea Industry Restraints Table 5. Global Fungal Drugs for Treatment of Tinea Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fungal Drugs for Treatment of Tinea Revenue Share by Company (2021-2026) Table 7. Global Fungal Drugs for Treatment of Tinea Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Fungal Drugs for Treatment of Tinea Key Company Manufacturing Base & Headquarters Table 9. Global Fungal Drugs for Treatment of Tinea Company, Product Type & Application Table 10. Global Fungal Drugs for Treatment of Tinea Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Fungal Drugs for Treatment of Tinea by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Topical Drugs Table 15. Significant Companies of Oral Drugs Table 16. Global Fungal Drugs for Treatment of Tinea Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Fungal Drugs for Treatment of Tinea Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Fungal Drugs for Treatment of Tinea Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Type (2021-2026) Table 20. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Pharmacy Table 22. Significant Companies of Online Table 23. Significant Companies of Retail Pharmacy Table 24. Global Fungal Drugs for Treatment of Tinea Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fungal Drugs for Treatment of Tinea Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Fungal Drugs for Treatment of Tinea Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Application (2021-2026) Table 28. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Application (2027-2032) Table 29. Global Fungal Drugs for Treatment of Tinea Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Fungal Drugs for Treatment of Tinea Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Region (2021-2026) Table 32. Global Fungal Drugs for Treatment of Tinea Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Region (2027-2032) Table 34. Global Fungal Drugs for Treatment of Tinea Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Fungal Drugs for Treatment of Tinea Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Fungal Drugs for Treatment of Tinea Sales Value Market Share by Country (2021-2026) Table 37. Global Fungal Drugs for Treatment of Tinea Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Fungal Drugs for Treatment of Tinea Sales Value Market Share by Country (2027-2032) Table 39. Tianjin Lisheng Pharmaceuticals Company Information Table 40. Tianjin Lisheng Pharmaceuticals Business Overview Table 41. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 43. Tianjin Lisheng Pharmaceuticals Recent Development Table 44. Teva Pharmaceuticals Company Information Table 45. Teva Pharmaceuticals Business Overview Table 46. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 48. Teva Pharmaceuticals Recent Development Table 49. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information Table 50. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview Table 51. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 53. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Development Table 54. Shandong Qilu Pharmaceuticals Company Information Table 55. Shandong Qilu Pharmaceuticals Business Overview Table 56. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 58. Shandong Qilu Pharmaceuticals Recent Development Table 59. Shandong Luoxin Pharmaceuticals Company Information Table 60. Shandong Luoxin Pharmaceuticals Business Overview Table 61. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 63. Shandong Luoxin Pharmaceuticals Recent Development Table 64. Shandong Jingwei Pharmaceutical Company Information Table 65. Shandong Jingwei Pharmaceutical Business Overview Table 66. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 68. Shandong Jingwei Pharmaceutical Recent Development Table 69. Sandoz Company Information Table 70. Sandoz Business Overview Table 71. Sandoz Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio Table 73. Sandoz Recent Development Table 74. Johnson & Johnson Company Information Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio Table 78. Johnson & Johnson Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis Fungal Drugs for Treatment of Tinea Product Portfolio Table 83. Novartis Recent Development Table 84. Jiangsu Zhiyuan Pharmaceutical Company Information Table 85. Jiangsu Zhiyuan Pharmaceutical Business Overview Table 86. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 88. Jiangsu Zhiyuan Pharmaceutical Recent Development Table 89. Jiangsu Yunyang Group Pharmaceuticals Company Information Table 90. Jiangsu Yunyang Group Pharmaceuticals Business Overview Table 91. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 93. Jiangsu Yunyang Group Pharmaceuticals Recent Development Table 94. Hubei Hengan Fulin Company Information Table 95. Hubei Hengan Fulin Business Overview Table 96. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio Table 98. Hubei Hengan Fulin Recent Development Table 99. Hainan Kangzhi Pharmaceuticals Company Information Table 100. Hainan Kangzhi Pharmaceuticals Business Overview Table 101. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 103. Hainan Kangzhi Pharmaceuticals Recent Development Table 104. Harbin Sanlian Pharmaceuticals Company Information Table 105. Harbin Sanlian Pharmaceuticals Business Overview Table 106. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 108. Harbin Sanlian Pharmaceuticals Recent Development Table 109. Guilin Huaxin Pharmaceuticals Company Information Table 110. Guilin Huaxin Pharmaceuticals Business Overview Table 111. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 113. Guilin Huaxin Pharmaceuticals Recent Development Table 114. GSK Company Information Table 115. GSK Business Overview Table 116. GSK Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. GSK Fungal Drugs for Treatment of Tinea Product Portfolio Table 118. GSK Recent Development Table 119. Chengdu Beite Pharmaceuticals Company Information Table 120. Chengdu Beite Pharmaceuticals Business Overview Table 121. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 123. Chengdu Beite Pharmaceuticals Recent Development Table 124. Bayer Company Information Table 125. Bayer Business Overview Table 126. Bayer Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Bayer Fungal Drugs for Treatment of Tinea Product Portfolio Table 128. Bayer Recent Development Table 129. Ultratech India Company Information Table 130. Ultratech India Business Overview Table 131. Ultratech India Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio Table 133. Ultratech India Recent Development Table 134. Perrigo Company Information Table 135. Perrigo Business Overview Table 136. Perrigo Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio Table 138. Perrigo Recent Development Table 139. Padagis Company Information Table 140. Padagis Business Overview Table 141. Padagis Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Padagis Fungal Drugs for Treatment of Tinea Product Portfolio Table 143. Padagis Recent Development Table 144. Kaken Pharmaceutical Company Information Table 145. Kaken Pharmaceutical Business Overview Table 146. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 148. Kaken Pharmaceutical Recent Development Table 149. Gufic Biosciences Company Information Table 150. Gufic Biosciences Business Overview Table 151. Gufic Biosciences Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio Table 153. Gufic Biosciences Recent Development Table 154. Galderma Company Information Table 155. Galderma Business Overview Table 156. Galderma Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Galderma Fungal Drugs for Treatment of Tinea Product Portfolio Table 158. Galderma Recent Development Table 159. Bausch Health Company Information Table 160. Bausch Health Business Overview Table 161. Bausch Health Fungal Drugs for Treatment of Tinea Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio Table 163. Bausch Health Recent Development Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Fungal Drugs for Treatment of Tinea Product Image Figure 2. Global Fungal Drugs for Treatment of Tinea Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fungal Drugs for Treatment of Tinea Market Size (2021-2032) & (US$ Million) Figure 4. Global Fungal Drugs for Treatment of Tinea Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Topical Drugs Image Figure 8. Oral Drugs Image Figure 9. Global Fungal Drugs for Treatment of Tinea Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Fungal Drugs for Treatment of Tinea Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Type (2021-2032) Figure 12. Hospital Pharmacy Image Figure 13. Online Image Figure 14. Retail Pharmacy Image Figure 15. Global Fungal Drugs for Treatment of Tinea Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Fungal Drugs for Treatment of Tinea Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Application (2021-2032) Figure 18. Global Fungal Drugs for Treatment of Tinea Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Fungal Drugs for Treatment of Tinea Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Fungal Drugs for Treatment of Tinea Sales Value (2021-2032) & (US$ Million) Figure 21. North America Fungal Drugs for Treatment of Tinea Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Fungal Drugs for Treatment of Tinea Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Fungal Drugs for Treatment of Tinea Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Fungal Drugs for Treatment of Tinea Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Fungal Drugs for Treatment of Tinea Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Fungal Drugs for Treatment of Tinea Sales Value (2021-2032) & (US$ Million) Figure 27. South America Fungal Drugs for Treatment of Tinea Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Fungal Drugs for Treatment of Tinea Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Fungal Drugs for Treatment of Tinea Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Drugs
  • Oral Drugs
Applications
  • Hospital Pharmacy
  • Online
  • Retail Pharmacy
Companies covered
  • Tianjin Lisheng Pharmaceuticals
  • Teva Pharmaceuticals
  • Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
  • Shandong Qilu Pharmaceuticals
  • Shandong Luoxin Pharmaceuticals
  • Shandong Jingwei Pharmaceutical
  • Sandoz
  • Johnson & Johnson
  • Novartis
  • Jiangsu Zhiyuan Pharmaceutical
  • Jiangsu Yunyang Group Pharmaceuticals
  • Hubei Hengan Fulin
  • Hainan Kangzhi Pharmaceuticals
  • Harbin Sanlian Pharmaceuticals
  • Guilin Huaxin Pharmaceuticals
  • GSK
  • Chengdu Beite Pharmaceuticals
  • Bayer
  • Ultratech India
  • Perrigo
  • Padagis
  • Kaken Pharmaceutical
  • Gufic Biosciences
  • Galderma
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fungal Drugs for Treatment of Tinea Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Fungal Drugs for Treatment of Tinea Market Dynamics
  1. 2.1 Fungal Drugs for Treatment of Tinea Industry Trends
  2. 2.2 Fungal Drugs for Treatment of Tinea Industry Drivers
  3. 2.3 Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges
  4. 2.4 Fungal Drugs for Treatment of Tinea Industry Restraints
3 Fungal Drugs for Treatment of Tinea Market by Company
  1. 3.1 Global Fungal Drugs for Treatment of Tinea Company Revenue Ranking in 2025
  2. 3.2 Global Fungal Drugs for Treatment of Tinea Revenue by Company (2021-2026)
  3. 3.3 Global Fungal Drugs for Treatment of Tinea Company Ranking (2024-2026)
  4. 3.4 Global Fungal Drugs for Treatment of Tinea Company Manufacturing Base and Headquarters
  5. 3.5 Global Fungal Drugs for Treatment of Tinea Company Product Type and Application
  6. 3.6 Global Fungal Drugs for Treatment of Tinea Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Fungal Drugs for Treatment of Tinea Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Fungal Drugs for Treatment of Tinea Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Fungal Drugs for Treatment of Tinea Market by Type
  1. 4.1 Fungal Drugs for Treatment of Tinea Type Introduction
  2. 4.1.1 Topical Drugs
  3. 4.1.2 Oral Drugs
  4. 4.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Type
  5. 4.2.1 Global Fungal Drugs for Treatment of Tinea Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Type (2021-2032)
  7. 4.2.3 Global Fungal Drugs for Treatment of Tinea Sales Value Share by Type (2021-2032)
5 Fungal Drugs for Treatment of Tinea Market by Application
  1. 5.1 Fungal Drugs for Treatment of Tinea Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Application
  6. 5.2.1 Global Fungal Drugs for Treatment of Tinea Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Application (2021-2032)
  8. 5.2.3 Global Fungal Drugs for Treatment of Tinea Sales Value Share by Application (2021-2032)
6 Fungal Drugs for Treatment of Tinea Regional Value Analysis
  1. 6.1 Global Fungal Drugs for Treatment of Tinea Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Region (2021-2032)
  3. 6.2.1 Global Fungal Drugs for Treatment of Tinea Sales Value by Region: 2021-2026
  4. 6.2.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fungal Drugs for Treatment of Tinea Sales Value (2021-2032)
  7. 6.3.2 North America Fungal Drugs for Treatment of Tinea Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Fungal Drugs for Treatment of Tinea Sales Value (2021-2032)
  10. 6.4.2 Europe Fungal Drugs for Treatment of Tinea Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Fungal Drugs for Treatment of Tinea Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Fungal Drugs for Treatment of Tinea Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Fungal Drugs for Treatment of Tinea Sales Value (2021-2032)
  16. 6.6.2 South America Fungal Drugs for Treatment of Tinea Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Fungal Drugs for Treatment of Tinea Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Fungal Drugs for Treatment of Tinea Sales Value Share by Country, 2025 VS 2032
7 Fungal Drugs for Treatment of Tinea Country-level Value Analysis
  1. 7.1 Global Fungal Drugs for Treatment of Tinea Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Country (2021-2032)
  3. 7.2.1 Global Fungal Drugs for Treatment of Tinea Sales Value by Country (2021-2026)
  4. 7.2.2 Global Fungal Drugs for Treatment of Tinea Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Fungal Drugs for Treatment of Tinea Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Fungal Drugs for Treatment of Tinea Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Fungal Drugs for Treatment of Tinea Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tianjin Lisheng Pharmaceuticals
  2. 8.1.1 Tianjin Lisheng Pharmaceuticals Company Information
  3. 8.1.2 Tianjin Lisheng Pharmaceuticals Business Overview
  4. 8.1.3 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  6. 8.1.5 Tianjin Lisheng Pharmaceuticals Recent Developments
  7. 8.2 Teva Pharmaceuticals
  8. 8.2.1 Teva Pharmaceuticals Company Information
  9. 8.2.2 Teva Pharmaceuticals Business Overview
  10. 8.2.3 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  12. 8.2.5 Teva Pharmaceuticals Recent Developments
  13. 8.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
  14. 8.3.1 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information
  15. 8.3.2 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
  16. 8.3.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  18. 8.3.5 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Developments
  19. 8.4 Shandong Qilu Pharmaceuticals
  20. 8.4.1 Shandong Qilu Pharmaceuticals Company Information
  21. 8.4.2 Shandong Qilu Pharmaceuticals Business Overview
  22. 8.4.3 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  24. 8.4.5 Shandong Qilu Pharmaceuticals Recent Developments
  25. 8.5 Shandong Luoxin Pharmaceuticals
  26. 8.5.1 Shandong Luoxin Pharmaceuticals Company Information
  27. 8.5.2 Shandong Luoxin Pharmaceuticals Business Overview
  28. 8.5.3 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  30. 8.5.5 Shandong Luoxin Pharmaceuticals Recent Developments
  31. 8.6 Shandong Jingwei Pharmaceutical
  32. 8.6.1 Shandong Jingwei Pharmaceutical Company Information
  33. 8.6.2 Shandong Jingwei Pharmaceutical Business Overview
  34. 8.6.3 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  36. 8.6.5 Shandong Jingwei Pharmaceutical Recent Developments
  37. 8.7 Sandoz
  38. 8.7.1 Sandoz Company Information
  39. 8.7.2 Sandoz Business Overview
  40. 8.7.3 Sandoz Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio
  42. 8.7.5 Sandoz Recent Developments
  43. 8.8 Johnson & Johnson
  44. 8.8.1 Johnson & Johnson Company Information
  45. 8.8.2 Johnson & Johnson Business Overview
  46. 8.8.3 Johnson & Johnson Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio
  48. 8.8.5 Johnson & Johnson Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Fungal Drugs for Treatment of Tinea Product Portfolio
  54. 8.9.5 Novartis Recent Developments
  55. 8.10 Jiangsu Zhiyuan Pharmaceutical
  56. 8.10.1 Jiangsu Zhiyuan Pharmaceutical Company Information
  57. 8.10.2 Jiangsu Zhiyuan Pharmaceutical Business Overview
  58. 8.10.3 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  60. 8.10.5 Jiangsu Zhiyuan Pharmaceutical Recent Developments
  61. 8.11 Jiangsu Yunyang Group Pharmaceuticals
  62. 8.11.1 Jiangsu Yunyang Group Pharmaceuticals Company Information
  63. 8.11.2 Jiangsu Yunyang Group Pharmaceuticals Business Overview
  64. 8.11.3 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  66. 8.11.5 Jiangsu Yunyang Group Pharmaceuticals Recent Developments
  67. 8.12 Hubei Hengan Fulin
  68. 8.12.1 Hubei Hengan Fulin Company Information
  69. 8.12.2 Hubei Hengan Fulin Business Overview
  70. 8.12.3 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio
  72. 8.12.5 Hubei Hengan Fulin Recent Developments
  73. 8.13 Hainan Kangzhi Pharmaceuticals
  74. 8.13.1 Hainan Kangzhi Pharmaceuticals Company Information
  75. 8.13.2 Hainan Kangzhi Pharmaceuticals Business Overview
  76. 8.13.3 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  78. 8.13.5 Hainan Kangzhi Pharmaceuticals Recent Developments
  79. 8.14 Harbin Sanlian Pharmaceuticals
  80. 8.14.1 Harbin Sanlian Pharmaceuticals Company Information
  81. 8.14.2 Harbin Sanlian Pharmaceuticals Business Overview
  82. 8.14.3 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  84. 8.14.5 Harbin Sanlian Pharmaceuticals Recent Developments
  85. 8.15 Guilin Huaxin Pharmaceuticals
  86. 8.15.1 Guilin Huaxin Pharmaceuticals Company Information
  87. 8.15.2 Guilin Huaxin Pharmaceuticals Business Overview
  88. 8.15.3 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  90. 8.15.5 Guilin Huaxin Pharmaceuticals Recent Developments
  91. 8.16 GSK
  92. 8.16.1 GSK Company Information
  93. 8.16.2 GSK Business Overview
  94. 8.16.3 GSK Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  95. 8.16.4 GSK Fungal Drugs for Treatment of Tinea Product Portfolio
  96. 8.16.5 GSK Recent Developments
  97. 8.17 Chengdu Beite Pharmaceuticals
  98. 8.17.1 Chengdu Beite Pharmaceuticals Company Information
  99. 8.17.2 Chengdu Beite Pharmaceuticals Business Overview
  100. 8.17.3 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  102. 8.17.5 Chengdu Beite Pharmaceuticals Recent Developments
  103. 8.18 Bayer
  104. 8.18.1 Bayer Company Information
  105. 8.18.2 Bayer Business Overview
  106. 8.18.3 Bayer Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bayer Fungal Drugs for Treatment of Tinea Product Portfolio
  108. 8.18.5 Bayer Recent Developments
  109. 8.19 Ultratech India
  110. 8.19.1 Ultratech India Company Information
  111. 8.19.2 Ultratech India Business Overview
  112. 8.19.3 Ultratech India Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio
  114. 8.19.5 Ultratech India Recent Developments
  115. 8.20 Perrigo
  116. 8.20.1 Perrigo Company Information
  117. 8.20.2 Perrigo Business Overview
  118. 8.20.3 Perrigo Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio
  120. 8.20.5 Perrigo Recent Developments
  121. 8.21 Padagis
  122. 8.21.1 Padagis Company Information
  123. 8.21.2 Padagis Business Overview
  124. 8.21.3 Padagis Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Padagis Fungal Drugs for Treatment of Tinea Product Portfolio
  126. 8.21.5 Padagis Recent Developments
  127. 8.22 Kaken Pharmaceutical
  128. 8.22.1 Kaken Pharmaceutical Company Information
  129. 8.22.2 Kaken Pharmaceutical Business Overview
  130. 8.22.3 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  132. 8.22.5 Kaken Pharmaceutical Recent Developments
  133. 8.23 Gufic Biosciences
  134. 8.23.1 Gufic Biosciences Company Information
  135. 8.23.2 Gufic Biosciences Business Overview
  136. 8.23.3 Gufic Biosciences Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio
  138. 8.23.5 Gufic Biosciences Recent Developments
  139. 8.24 Galderma
  140. 8.24.1 Galderma Company Information
  141. 8.24.2 Galderma Business Overview
  142. 8.24.3 Galderma Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Galderma Fungal Drugs for Treatment of Tinea Product Portfolio
  144. 8.24.5 Galderma Recent Developments
  145. 8.25 Bausch Health
  146. 8.25.1 Bausch Health Company Information
  147. 8.25.2 Bausch Health Business Overview
  148. 8.25.3 Bausch Health Fungal Drugs for Treatment of Tinea Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio
  150. 8.25.5 Bausch Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst